Inflammatory myocardial diseases and cardiomyopathies (Q41526280)

2 October 2017

1 reference

title

Inflammatory myocardial diseases and cardiomyopathies (English)

1 reference

2 October 2017

Pisani B

1

1 reference

2 October 2017

Taylor DO

series ordinal

2

1 reference

2 October 2017

Mason JW

series ordinal

3

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

American Journal of Medicine

2 October 2017

1 reference

2 October 2017

102

1 reference

2 October 2017

5

1 reference

2 October 2017

459-469

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Myocarditis and idiopathic dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Anti-idiotype-pulsed B cells in the induction and expression of autoimmune myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Pernicious anemia and giant cell myocarditis. New association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

7 January 2021

Giant cell myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

7 January 2021

Sarcoidosis of the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Peripartum cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Peripartum myocarditis and cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Peripartum cardiomyopathy due to myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Incidence of myocarditis in peripartum cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Heart disease and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Cardiac manifestations of acquired immune deficiency syndrome: A 1991 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Pathogenesis of infection with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Immunopathogenesis of HIV-1-associated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Clinical profile of biopsy proven idiopathic myocarditis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

A clinicopathologic description of myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Clinicopathologic description of myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Beta-adrenoceptor antibodies and genetics in dilated cardiomyopathy-- An overview and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Evidence from family studies for autoimmunity in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Antibodies to Coxsackie B viruses in congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

"Borderline" myocarditis: an indication for repeat endomyocardial biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Acute myocarditis. Rapid diagnosis by PCR in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte subpopulations and the inflammatory reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Gamma-globulin treatment of acute myocarditis in the pediatric population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

FK506 therapy of experimental autoimmune myocarditis after onset of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Effect of metoprolol in acute coxsackievirus B3 murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Verapamil ameliorates the clinical and pathological course of murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900331-8

10.1016/S0002-9343(97)00331-8

7 January 2021

Identifiers

DOI

1 reference

2 October 2017

1 reference